TRNR Announces 1-for-100 Reverse Split

November 7, 2024 7:00 AM

Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-100. The reverse stock split will become effective on November 11, 2024, and the Company's common stock will begin trading on a post-split basis at the market open on November 11,...

Read more

Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates

November 7, 2024 6:30 AM

CAMBRIDGE, MA / ACCESSWIRE / November 7, 2024 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the third quarter of 2024."During the third quarter, we focused on execution with the launch of our updated COVID-19 and RSV vaccines in markets across the globe. I am pleased with the cost efficiency we achieved in the quarter, tracking ahead of where we planned to be at this time," said Stéphane Bancel,...

Read more

Enteralia Bioscience SRL Acquires TFarma SRL

November 7, 2024 3:00 AM

Enteralia Bioscience SRL Acquires TFarma to Strengthen Presence in Italy's Nutraceutical and Medical Device MarketMILAN, ITALY / ACCESSWIRE / November 7, 2024 / Enteralia Bioscience SRL ("Enteralia") is pleased to announce the acquisition of TFarma, a well-established company focused on the sales and marketing of nutraceuticals and medical devices in Italy. This strategic acquisition marks a key milestone in Enteralia's expansion within the...

Read more

Quarterly Report Q3: Successful Outcome from Rights Issue with SEK 105 Million Extends Runway Until Late 2025

November 7, 2024 2:30 AM

MALMÖ, SWEDEN / ACCESSWIRE / November 7, 2024 / Ascelia Pharma (STO:ACE)Ascelia Pharma AB (publ) (ticker: ACE) today published its Interim Report Q3 for 2024 (January - September), which is now available on the company's website: https://www.ascelia.com/ir-media/financial-reports/KEY EVENTS IN Q3 2024Ascelia Pharma carries out a Rights Issue of units of approximately SEK 105 millionNotice of and bulletin from Extraordinary General Meeting on 14...

Read more

Global Peri-Implantitis Treatment Market to Surge, Projected to Reach USD 5,191.9 million by 2034 Amid Rising Demand for Dental Implants | FMI

November 7, 2024 2:30 AM

The global market for peri-implantitis treatment is set to experience significant growth, with market value expected to rise from USD 2,689.1 million in 2024 to USD 5,191.9 million by 2034. Driven by a compound annual growth rate (CAGR) of 6.8% over the next decade, this increase reflects heightened demand and a growing awareness of peri-implantitis management among both patients and dental professionals.Peri-implantitis, a local infectious...

Read more

Safdar Family Law & Mediation Group, a Firm Gaining Notice for Promoting Mediation Through Conflict, Celebrates Fifth Anniversary

November 6, 2024 11:40 PM

NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Attorney-Mediator Talaiya Safdar, founder of Safdar Family Law & Mediation Group, is pleased to announce the firm is celebrating five years of helping clients through one of the most difficult things a person can experience. Throughout that time, the firm has earned attention by advocating for mediation before divorce. Safdar is a certified mediation expert, and her work can save both sides time,...

Read more

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

November 6, 2024 5:20 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its first quarter of fiscal 2025, after the market close on Wednesday, November 13, 2024. The Company has scheduled a conference call and webcast that same day, Wednesday, November 13, 2024, at 4:30 p.m. Eastern time, to review the results followed by a...

Read more

Ascelia Pharma Announces Completion of Full Study Report Reinforcing the Successful Outcomes of Orviglance Phase 3 Study SPARKLE

November 6, 2024 5:05 PM

MALMÖ, SWEDEN / ACCESSWIRE / November 06, 2024 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced the completion of the Full Study Report for the pivotal Phase 3 Study for Orviglance® liver imaging drug candidate, which includes the previously announced strong results of primary endpoints. In addition, the results of secondary...

Read more

Ainos Reports Third Quarter 2024 Financial Results

November 6, 2024 4:30 PM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") and low-dose interferon therapeutics, today announced its financial results for the third quarter ended September 30, 2024.Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, "In Q3, we made significant strides in executing our...

Read more

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

November 6, 2024 4:05 PM

Reports Net Revenues of $191.2 Million for the Three Months Ended September 30, 2024RANCHO CUCAMONGA, CA / ACCESSWIRE / November 6, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2024.Third quarter HighlightsNet revenues of $191.2 million for the third quarterGAAP net income of $40.4 million, or $0.78 per share, for the third quarterAdjusted...

Read more

OptiMed Health Partners Earns ACHC Accreditation Once Again

November 6, 2024 3:30 PM

Reaccreditation Highlights OptiMed's Continued Commitment to Excellence in Patient Care and Quality StandardsKALAMAZOO, MI / ACCESSWIRE / November 6, 2024 / OptiMed Health Partners proudly announces it has achieved accreditation through Accreditation Commission for Health Care (ACHC) for the services of specialty pharmacy and ambulatory infusion center.ACHC Gold Seal of Accreditation "The three-year accreditation renewal underscores OptiMed's...

Read more

Notice of extraordinary general meeting in Cantargia AB (publ)

November 6, 2024 12:15 PM

LUND, SE / ACCESSWIRE / November 6, 2024 / Cantargia (STO:CANTA) The shareholders of Cantargia AB (publ) are invited to the extraordinary general meeting on Monday, 2 December 2024, at 10.00 CET at Ideon Gateway, Scheelevägen 27, Lund, Sweden.Right to participate and noticeParticipation at the venueShareholders who wish to participate in the meeting at the venue in person or represented by a proxy must:be recorded in the share register...

Read more

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea in Dogs

November 6, 2024 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / November 6, 2024 / Jaguar Health, Inc.(NASDAQ:JAGX), under its Jaguar Animal Health tradename for the veterinary market, today announced that the U.S. Food and Drug Administration (FDA) has approved renewal of Canalevia-CA1 (crofelemer delayed-release tablets). Canalevia-CA1, the company's conditionally approved prescription drug for the treatment of chemotherapy-induced diarrhea (CID) in dogs, is available from...

Read more

Holland Foundation for Sight Restoration Announces Partnership With Mass Eye and Ear

November 6, 2024 10:00 AM

Third Holland Foundation Center of Excellence To Be EstablishedBOSTON, MA / ACCESSWIRE / November 6, 2024 / The Holland Foundation for Sight Restoration is proud to announce a partnership with the prestigious Mass Eye and Ear to establish the Foundation's third Center of Excellence in the United States.Led by Thomas Dohlman, MD, Medical Director of the Boston Keratoprosthesis Program at Mass Eye and Ear and an assistant professor of...

Read more

Omaha-Based Healthcare Company Fusion Gathers Employees for Project Pink'd Fundraiser

November 6, 2024 10:00 AM

OMAHA, NB / ACCESSWIRE / November 6, 2024 / In honor of breast cancer awareness month, Fusion held a company outing and fundraiser last month, raising more than $20,000 for breast cancer support and research. The beneficiary was Project Pink'd, an organization that supports those diagnosed with breast cancer in several ways, including financially, emotionally, and physically. Fusion raises money for Project Pink'd "Fusion came together and did...

Read more

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

November 6, 2024 8:00 AM

FORT LAUDERDALE, FL / ACCESSWIRE / November 6, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 third quarter report with the Securities and Exchange Commission. The Company reported gross revenues of $8,435,178 for the three months ended September 30,...

Read more

Interim Report January - September 2024: Strong Sales Growth Driven by Accelerated Sensor Sales

November 6, 2024 2:50 AM

UPPSALA, SE / ACCESSWIRE / November 06, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, November 6th, 2024. Senzime AB's (publ) interim report for January - September 2024 is now available on the company's website www.senzime.com.Financial information July - September 2024• Net sales amounted to TSEK 17,406 (9,154), an increase of 90 percent.• Currency-adjusted net sales increased by 98 percent.• Sales of disposable sensors...

Read more

Spago Nanomedical Interim Report January-September 2024

November 6, 2024 2:20 AM

LUND, SWEDEN / ACCESSWIRE / November 6, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Progress for the Tumorad programJULY - SEPTEMBER IN BRIEFNet sales for the quarter amounted to KSEK 485 (KSEK 271)The loss for the quarter amounted to KSEK -8,763 (KSEK -7,755)Operating expenses for the quarter amounted to KSEK -10,650 (KSEK -8,795)Earnings per share, before and after dilution, for the quarter amounted to SEK -0.03 (SEK -0.09)JANUARY -...

Read more

"The Senior Care Influencer" Lance A. Slatton becomes Official Brand Ambassador for Echobox Memory Vault

November 6, 2024 1:20 AM

Lance A. Slatton, known throughout the health care and senior living community as "The Senior Care Influencer," was recently named as Official Brand Ambassador for Echobox Memory Vault. Slatton, a writer, author, and healthcare professional with over 20 years in the healthcare industry, hosts the award-winning and popular podcast and YouTube show "All Home Care Matters," and is a senior case manager at Enriched Life Home Care Services in...

Read more

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions

November 6, 2024 1:20 AM

Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) today announced its financial results and corporate updates for the third quarter of 2024, highlighting strategic progress across key partnerships and operations.Dr Christian Wojczewski, Chief Executive Officer of Evotec, said: "We continue to deliver on the successful execution of our Priority Reset and have achieved significant progress across key...

Read more